100 related articles for article (PubMed ID: 10560360)
1. Posaconazole prophylaxis in hematologic cancer.
Weiler S; Bellmann R
N Engl J Med; 2007 May; 356(21):2214; author reply 2215-8. PubMed ID: 17522407
[No Abstract] [Full Text] [Related]
2. The importance of cleanrooms for the treatment of haemato-oncological patients.
Holý O; Matoušková I
Contemp Oncol (Pozn); 2012; 16(3):266-72. PubMed ID: 23788892
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
Wang J; Zhou M; Xu JY; Zhou RF; Chen B; Wan Y
JAMA Netw Open; 2020 Oct; 3(10):e2017652. PubMed ID: 33030550
[TBL] [Abstract][Full Text] [Related]
4. Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.
Lee CH; Lin C; Ho CL; Lin JC
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866872
[TBL] [Abstract][Full Text] [Related]
5. Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials.
Ethier MC; Science M; Beyene J; Briel M; Lehrnbecher T; Sung L
Br J Cancer; 2012 May; 106(10):1626-37. PubMed ID: 22568999
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.
Lee DG; Kim SH; Kim SY; Kim CJ; Park WB; Song YG; Choi JH
Korean J Intern Med; 2011 Jun; 26(2):220-52. PubMed ID: 21716917
[TBL] [Abstract][Full Text] [Related]
7. Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis.
Imataki O; Kubota Y; Ohnishi H; Kitanaka A; Ishida T; Tanaka T
Support Care Cancer; 2011 Oct; 19(10):1657-65. PubMed ID: 20830490
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of oral fungal infections in patients receiving cancer therapy.
Lalla RV; Latortue MC; Hong CH; Ariyawardana A; D'Amato-Palumbo S; Fischer DJ; Martof A; Nicolatou-Galitis O; Patton LL; Elting LS; Spijkervet FK; Brennan MT;
Support Care Cancer; 2010 Aug; 18(8):985-92. PubMed ID: 20449755
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials.
Wang J; Zhan P; Zhou R; Xu J; Shao X; Yang Y; Ouyang J
Med Oncol; 2010 Dec; 27(4):1082-8. PubMed ID: 19876778
[TBL] [Abstract][Full Text] [Related]
10. Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
Cornely OA; Böhme A; Buchheidt D; Einsele H; Heinz WJ; Karthaus M; Krause SW; Krüger W; Maschmeyer G; Penack O; Ritter J; Ruhnke M; Sandherr M; Sieniawski M; Vehreschild JJ; Wolf HH; Ullmann AJ
Haematologica; 2009 Jan; 94(1):113-22. PubMed ID: 19066334
[TBL] [Abstract][Full Text] [Related]
11. The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.
Ito Y; Ohyashiki K; Yoshida I; Takeuchi M; Aoyama Y; Mugitani A; Matsuura Y; Wakita H; Matsuda M; Sakamoto E; Kiguchi T; Urabe A; Tamura K; Kanamaru A; Masaoka T
Int J Hematol; 2007 Feb; 85(2):121-7. PubMed ID: 17321989
[TBL] [Abstract][Full Text] [Related]
12. Interventions for preventing oral candidiasis for patients with cancer receiving treatment.
Clarkson JE; Worthington HV; Eden OB
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD003807. PubMed ID: 17253497
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with itraconazole in systemic fungal infections.
Boogaerts M; Maertens J
Drugs; 2001; 61 Suppl 1():39-47. PubMed ID: 11219549
[TBL] [Abstract][Full Text] [Related]
14. Current management of fungal infections.
Meis JF; Verweij PE
Drugs; 2001; 61 Suppl 1():13-25. PubMed ID: 11219547
[TBL] [Abstract][Full Text] [Related]
15. Fungal infections in patients with neutropenia: challenges in prophylaxis and treatment.
Herbrecht R; Neuville S; Letscher-Bru V; Natarajan-Amé S; Lortholary O
Drugs Aging; 2000 Nov; 17(5):339-51. PubMed ID: 11190415
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
Huijgens PC; Simoons-Smit AM; van Loenen AC; Prooy E; van Tinteren H; Ossenkoppele GJ; Jonkhoff AR
J Clin Pathol; 1999 May; 52(5):376-80. PubMed ID: 10560360
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
